Soluble CA IX in serum or plasma can be used as a diagnostic marker in patients with renal cell carcinoma [17], breast cancer [18], non-small cell lung cancer [19], rectal cancer [20], or testicular cancer [21]. This evidence concerns the gene CA9 and rectal cancer.